Company profile
Delivra Health Brands Inc.
OTC: DHBUF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#640 of 1,422 Healthcare companies by revenue48th-percentile growth
EA Score
54DFH 53DQ —GM 65SS 41
v0.1 · 45/100 weight · provisional
↑ growth stability, return on assets · ↓ Piotroski F, Altman-Z
Methodology →Revenue TTM
$8.1M
Rev growth YoY (TTM)
-10.3%
Net income (FY)
-$626.4k
Employees
22
as of 2026-08-25
Market cap
$2.7M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.6M13.4M CAD2025
Net income-$626.4k-874.1k CAD2025
Operating income-$442.7k-617.7k CAD2025
Total assets$7.0M9.6M CAD2025
Liabilities$2.9M3.9M CAD2025
Equity$2.3M3.1M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Delivra Health Brands Inc.’s revenue?
Delivra Health Brands Inc. booked $9.6M in FY2025 revenue, growing 4.9% year over year — about the middle of the pack among Healthcare companies we track, at a -6.5% net margin.
Peers · Healthcare
Taysha Gene Therapies, Inc.48DCalithera Biosciences, Inc.——Precigen, Inc.44DYulong Eco-Materials Limited——ThermoGenesis Holdings, Inc.——Curis, Inc.53DKey facts
CEOGord Davey
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: DHBUF
Employees22
IPO date2017-05-02
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.